U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07278102) titled 'A Prospective Observational Study on Efficacy of TARE for Early Stage HCC' on Nov. 29.
Brief Summary: The aim of the current study is to analyze treatment outcomes (best target lesion response, overall survival, time to target lesion progression, time to overall progression, and treatment-related adverse event) using prospectively collected clinical and imaging data in patients with BCLC 0 or A HCCs treated with TheraSphere(R) in four large-volume hospitals from Korea. The results will pave the way for expanding 90Y-TARE indication and refining reimbursement guidelines, and provide baseline data for possible subsequent future studie...